P. Wysocki

Genetically modified tumour vaccines: an obstacle race to break host tolerance to cancer

A. Mackiewicz, P. Wysocki, S. Nawrocki, 2001, Expert opinion on biological therapy.

Humoral responses to melanoma vaccine, genetically modified with interleukin 6 and soluble interleukin 6 receptor.

P. Murawa, J. Malicki, S. Rose-John, 2001, Advances in experimental medicine and biology.

Genetically modified dendritic cells – a new, promising cancer treatment strategy?

D. Kowalczyk, P. Wysocki, P. Grabarczyk, 2002, Expert opinion on biological therapy.

Cardiovascular complications associated with biological therapies for breast cancer

H. Wysocki, P. Wysocki, 2008 .

Flow cytometric cytotoxicity assay with GFP gene modified target cells.

D. Kowalczyk, P. Grabarczyk, D. Iżycki, 2001, Advances in experimental medicine and biology.

Improving the retroviral vector (RV) systems for immunotherapy of cancer.

P. Grabarczyk, D. Iżycki, K. Gryska, 2001, Advances in experimental medicine and biology.